MESOEYE C71 - 30@0=B8@>20==K9 @57C;LB0B @5H5=8O MAB5B8G5A:8E ?@>1;5< 2 ?5@8>@18B0;L=>9 >1;0AB8 2 8B8=>, !B@>38=>, "CH8=>, C@:8=>, @0A=>3>@A:

	>A<5B>;>38O

-	C25;8G5=85 3C1

-	=8B8 Dermafil

-	=8B52>9 3D ;8DB8=3 =8BO<8 Rose

-	B@54;8DB8=3 <57>=8BO<8 Beaute lift V-LINE

-	?;07<>B5@0?8O

-	?;07<5==0O 1;5D0@>?;0AB8:0

-	Meso-Wharton P199

-	MESOEYE C71

-	MESOSCULPT C71

-	B5@<>;8DB8=3 (@048>2>;=>2>9 ;8DB8=3) TriLipo RF

-	D@0:F8>==>5 ><>;>65=85

-	;075@=0O M?8;OF8O

-	D>B>><>;>65=85

-	CE>4 70 :>659 =0 1075 ?@>D5AA8>=0;L=>9 :>A<5B8:8 Natura Bisse (A?0=8O)

-	E8<8G5A:85 ?8;8=38

-	<57>B5@0?8O Dermaheal

-	>7>=>B5@0?8O

-	18>@528B0;870F8O :>68 (IAL-System, Surgilift, AcHyal)

-	>1J5<=0O :>=BC@=0O ?;0AB8:0

-	18>D8;;5@K ELLNSE @52>;NF8O 2 :>=BC@=>9 ?;0AB8:5!

-	D8;;5@ Radiesse

-	48A?>@B

-	1>B>:A

-	1>BC;0:A

-	0:20H09=

-	?@>3@0<

-	<8>AB8

-	C40;5=85 A>AC48ABKE 72Q74>G5:

-	:>@@5:F8O 38?5@384@>70

	8;8=38

-	?8;8=3 PRX-T33

-	?8;8=3 65AA=5@0

-	A0;8F8;>2K9 ?8;8=3

-	?8;8=3 Skin Tech

-	6Q;BK9 ?8;8=3

-	<8=40;L=K9 ?8;8=3

	>@@5:F8O D83C@K 8 CE>4 70 B5;><:

-	:@8>;8?>;87 COCCON

-	McBody B2 :>@@5:F8O D83C@K 8 :>=BC@0 ;8F0

-	C;LB@072C:>20O ;8?>A0:F8O - :028B0F8O

-	?@>3@0<

-	AQUALYX =5E8@C@38G5A:0O :>@@5:F8O ;>:0;L=KE 68@>2KE >B;>65=89

-	D>B>M?8;OF8O

-	;075@=0O M?8;OF8O

MESOEYE C71" - 8==>20F8>==K9 8=J5:F8>==K9 ?@5?0@0B A C=8:0;L=K<8 70?0B5=B>20==K<8 ?5?B840<8: 4;O 1KAB@>3>, MDD5:B82=>3> 8 157>?0A=>3> @5H5=8O MAB5B8G5A:8E ?@>1;5< ?5@8>@18B0;L=>9 >1;0AB8 157 E8@C@38G5A:>3> 2<5H0B5;LAB20.

>:070=8O : ?@8<5=5=8N MESOEYE C71":

!=865=85 B>=CA0 8 BC@3>@0 :>68.
0AB>7=>ABL.
>@@5:F8O ?5@8>@18B0;L=KE 3@K6 (=0G0;L=0O AB048O D>@<8@>20=8O).
!B>9:0O >B5G=>ABL ?@8 45D>@<0F8>==>->B5G=><, CAB0;>< 8 A<5H0==>< <>@D>B8?0E AB0@5=8O.
"5<=K5 :@C38 ?>4 3;070<8.
8<8G5A:85 <>@I8=K ?>4 3;070<8 8 2 C3>;:0E 3;07 (:>@@5:F8O "3CA8=KE ;0?>:").
>@@5:F8O <0;O@=KE 68@>2KE "?0:5B>2".
>43>B>2:0 ?0F85=B>2 : 1;5D0@>?;0AB8:5 (?>A;54=OO 8=J5:F8O 4>;6=0 1KBL ?@>2545=0 70 1 <5AOF 4> ?;0=8@C5<>9 >?5@0F88).
5018;8B0F8O ?5@8>@18B0;L=>9 >1;0AB8 ?>A;5 1;5D0@>?;0AB8:8.

;NG52K5 :> =5=BK MESOEYE C71":

PeriOrbital Peptide XP2 - C7:>A?5F8D8G5A:89 8=3818B>@ $: CAB@0=O5B A?07< 0@B5@8>;; C;CGH05B <8:@>35<>F8@:C;OF8N 2 45@<5 8 ?>4:>6=>9 68@>2>9 :;5BG0B:5; CAB@0=O5B ?0B>;>38G5A:>5 @0AH8@5=85 A>AC4>2 25=>7=>9 A8AB5<5=LH05B 8E ?@>=8F05<>ABL6 >1;0405B 3;8:0F88=3818@CNI59 0:B82=>ABL - A?>A>1AB2C5B 2>AAB0=>2;5=8N 8 70I8B5 :>;;035=>2KE 8 M;0AB8=>2KE 2>;>:>=.
Hexapeptide 17- 70?0B5=B>20==K9 ?5?B84 A C=8:0;L=K<8 A2>9AB20<8: >1;0405B A@>4AB2>< : >?80B=K< @5F5?B>@0< A>AC4>2, >:07K20O <>I=>5 ?@O<>5 ;84@5=06=>5 459AB285; >15A?5G8205B 0:B82870F8N B@0=A<5<1@0==>3> B@0=A?>@B0, <5=O5B A2>9AB20 <56:;5B>G=>9 684:>AB8 8 ?>2KH05B C@>25=L 0:B82=>3> ;84@5=060, GB> A=8605B >B5G=>ABL B:0=59 8 ?>2KH05B 18>4>ABC?=>ABL 4@C38E :> =5=B>2; C;CGH05B <8:@>F8@:C;OF8N; >1;0405B 207>?@>B5:B>@=K<8 A2>9AB20<8; >:07K205B ;8?><>48D8F8@CNI55 459AB285 - CA8;8205B D878>;>38G5A:89 ;8?>;87.

@C385 :> =5=BK:

#=8:0;L=>ABL <5E0=87<0 459AB28O MESOEYE C71":

0?@02;5==>5 207>?@>B5:B>@=>5 459AB285: >?B8<878@C5B 8 <>48D8F8@C5B @01>BC 0@B5@80;L=>9, 25=>7=>9 8 ;89 A8AB5< ?5@8>@18B0;L=>9 >1;0AB8.
#;CGH5=85 <8:@>F8@:C;OF88, ;8>BB>:0 8 ;84@5=060.
>AAB0=>2;5=85 8 70I8B0 :>;;035=>2KE, M;0AB8=>2KE 2>;>:>= 8 4@C38E <0:@><>;5:C;O@=KE :> =5=B>2 <56:;5B>G=>3> <0B@8:A0 >B >1@07>20=8O :>20;5=B=KE AH82>: 2 @57C;LB0B5 3;8:0F88.
5@<>@5<>45;8@>20=85, C;CGH5=85 AB@C:BC@=>-DC=:F8>=0;L=>3> A>AB>O=8O 8 @528B0;870F88 :>68.

MESOEYE C71" ?@5?0@0B <548F8=A:>3> =07=0G5=8O. 538AB@0F8>==>5 C4>AB>25@5=85 2016/4773 >B 19.09.2016 . 07@01>B0= A?5F80;8AB0<8 ABG LAB LLC (USA).

!B>8<>ABL ?@>F54C@K 12 000 @C1.